AAAAAA
Results: 101-125/482
Authors:
Canivet, N
Hollander, K
Mousnier, JP
Quaranta, JF
Citation: N. Canivet et al., Material vigilance: vigilance in the use of medical devices, TRANSF CL B, 7(1), 2000, pp. 96-100
Authors:
Barin, F
Citation: F. Barin, Viruses and prions: update on blood safety, TRANSF CL B, 7, 2000, pp. 5S-10S
Authors:
Coste, J
Citation: J. Coste, Viral nucleic acid testing in blood supply, TRANSF CL B, 7, 2000, pp. 11S-17S
Authors:
Laperche, S
Maniez-Montreuil, M
Courouce, AM
Citation: S. Laperche et al., p24 Ag/anti-HIV combined tests in early HIV-1 infection, TRANSF CL B, 7, 2000, pp. 18S-24S
Authors:
Maniez-Montreuil, M
Dubois, F
Citation: M. Maniez-montreuil et F. Dubois, Interpretation of hepatitis C virus serology: immunoblot assay and genomicamplification, TRANSF CL B, 7, 2000, pp. 25S-30S
Authors:
Mazeron, MC
Citation: Mc. Mazeron, Leukodepletion and infection by cytomegalovirus, TRANSF CL B, 7, 2000, pp. 31S-35S
Authors:
Rouger, P
Citation: P. Rouger, Immunohematology practices, TRANSF CL B, 7, 2000, pp. 36S-39S
Authors:
Le Pennec, PY
Citation: Py. Le Pennec, Evolution of reagents in erythrocyte immunohematology, TRANSF CL B, 7, 2000, pp. 40S-43S
Authors:
Chiaroni, J
Mannessier, L
Citation: J. Chiaroni et L. Mannessier, Methodological evolutions in immunohematology, TRANSF CL B, 7, 2000, pp. 44S-50S
Authors:
Mannessier, L
Roubinet, F
Delamaire, M
Chiaroni, J
Lejealle, A
Citation: L. Mannessier et al., Analytical validation in erythrocyte immunohematology, TRANSF CL B, 7, 2000, pp. 51S-54S
Authors:
Morel, P
des Floris, MFL
Bardiaux, L
Pouthier, F
Herve, P
Citation: P. Morel et al., Transfusion of blood components and bacterial risk, TRANSF CL B, 7, 2000, pp. 55S-62S
Authors:
Boval, B
Citation: B. Boval, Flow cytometry and its applications in transfusion medicine, TRANSF CL B, 7, 2000, pp. 63S-68S
Authors:
Wautier, JL
Citation: Jl. Wautier, Platelet immunological tests, TRANSF CL B, 7, 2000, pp. 69S-71S
Authors:
Pelissier, E
Nguyen, L
Citation: E. Pelissier et L. Nguyen, Traceability of blood products: definition, regulations, evaluation and perspectives, TRANSF CL B, 7, 2000, pp. 72S-74S
Authors:
Cabaud, JJ
Citation: Jj. Cabaud, Audit of blood product supplies and provisions, TRANSF CL B, 7, 2000, pp. 75S-79S
Authors:
Ruiz, A
Citation: A. Ruiz, Analysis of an information network, TRANSF CL B, 7, 2000, pp. 80S-83S
Authors:
Danic, B
Beauplet, A
Citation: B. Danic et A. Beauplet, The physician's role in blood donation sites, TRANSF CL B, 7, 2000, pp. 84S-87S
Authors:
Rouger, P
Citation: P. Rouger, Transfusion medicine: from myth to reality, TRANSF CL B, 6(6), 1999, pp. 341-341
Authors:
Herve, P
Citation: P. Herve, Transfusion medicine: discussion, field of application, stakes, TRANSF CL B, 6(6), 1999, pp. 342-348
Authors:
Wautier, JL
Citation: Jl. Wautier, Evidence-based transfusion medicine and medical training, TRANSF CL B, 6(6), 1999, pp. 349-354
Authors:
Schini-Kerth, VB
Citation: Vb. Schini-kerth, Vascular biosynthesis of nitric oxide: effect on hemostasis and fibrinolysis, TRANSF CL B, 6(6), 1999, pp. 355-363
Authors:
Douay, L
Citation: L. Douay, Developments of cellular therapy in the year 2000, TRANSF CL B, 6(6), 1999, pp. 364-369
Authors:
Rosencher, N
Woimant, G
Ozier, Y
Conseiller, C
Citation: N. Rosencher et al., Preoperative blood management and the role of erythropoietin in orthopedicsurgery, TRANSF CL B, 6(6), 1999, pp. 370-379
Authors:
Courouce, AM
Citation: Am. Courouce, Sensitivity of anti-HIV screening assays. Reevaluation 1999, TRANSF CL B, 6(6), 1999, pp. 381-394
Authors:
Wautier, JL
Wautier, MP
Citation: Jl. Wautier et Mp. Wautier, Erythrocyte adhesion to the vascular endothelium, TRANSF CL B, 6(6), 1999, pp. 397-402